Post-Transplant Solutions

Post-Transplant Monitoring Solutions

Providing precision and ease of use to deliver vital information

Having trouble viewing this video? Click here.

As the trusted partner of HLA labs around the world, the Transplant Diagnostics business of Thermo Fisher Scientific provides essential assays to deliver reliable and actionable data. The One Lambda™ LABScreen™ Single Antigen bead test is the gold standard for the detection of donor-specific antibodies and for clinical risk stratification with advanced data analytics. Additionally, MMDx® Kidney, Heart and Lung complement conventional biopsy processing to improve the assessment of rejection and injury in post-transplant care. 

Essential Post-Transplant Monitoring

The clinical and research segments of the transplant community play critical roles in patient care and monitoring. Our post-transplant diagnostic tests are designed to provide the precision and ease of use that laboratory professionals need to deliver the vital information that clinicians rely on. We understand that transplant patients have come a long way to reach this milestone, and we are committed to supporting them—as well as the professionals who contribute to their care—throughout this phase of their transplant journey.

To support ongoing patient monitoring, we offer assays to help laboratory professionals detect antibodies that can lead to rejection, as well as a service to aid in post-transplant biopsy assessment.


Expand your lab's capabilities with Antibody Monitoring
Learn more about the importance of monitoring

Antibody Monitoring   ❯

Our integrated solutions are used to identify HLA and non-HLA antibodies that may cause graft rejection. All products are designed to help laboratory professionals work efficiently and are optimized for automation.

Manage Post Transplant Treatment with Confidence
Learn how MMDx works

Molecular Biopsy Assessment   ❯

The Molecular Microscope® Diagnostic System (MMDx®) is a laboratory based service that provides objective and reproducible transplant biopsy assessments. The service complements conventional biopsy processing to help improve the assessment of rejection and injury in transplanted organs.